GUANGZHOU, China, Dec. 1 /Xinhua-PRNewswire/ -- China Medicine
Corporation, a domestic distributor of medical products, traditional
pharmaceutical and Chinese medicines, herbs and dietary supplements announced
today that its stock has been approved for quotation on the over-the-counter
Bulletin Board under the ticker symbol CHME.
About China Medicine Corporation:
China Medicine is a distributor of medical products, traditional
pharmaceutical medicines, traditional Chinese medicines, Chinese herbs and
dietary supplements to over 28 provinces and 2,500 customers within China. The
Company sells more than 1,100 products and is actively building a pipeline of
proprietary traditional and Chinese herbal remedy products targeting oncology,
high blood pressure and the removal of Aflatoxins from food and animal feed.
For more information visit the Company's website at
http://www.chinamedicinecorp.com .
Safe Harbor Statement:
This press release may contain forward-looking statements concerning China
Medicine Corporation's business and products. The actual results may differ
materially depending on a number of risk factors including, but not limited
to, the following: general economic and business conditions, development,
shipment, market acceptance, additional competition from existing and new
competitors, changes in technology, and various other factors beyond its
control. All forward-looking statements are expressly qualified in their
entirety by this Cautionary Statement and the risks factors detailed in the
Company's reports filed with the Securities and Exchange Commission. China
Medicine Corporation undertakes no duty to revise or update any forward-
looking statements to reflect events or circumstances after the date of this
release.
